4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine

C86H106N30O2S — CID 161066707

IUPAC4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine
SMILESCC(C)n1cc(-c2nc(-c3cnn(C4CCNCC4)c3)cn3nccc23)cn1.CCC(CC)n1cc(-c2nc(-c3cnn(C4CCNCC4)c3)cn3nccc23)cn1.CCC(CC)n1cc(-c2nc(-c3cnn(CC4CCCC4)c3)cn3nccc23)cn1.CC[C@@H](C)n1cc(-c2nc(-c3cnn(C4CCS(=O)(=O)CC4)c3)cn3nccc23)cn1
InChIInChI=1S/C23H29N7.C22H28N8.C21H25N7O2S.C20H24N8/c1-3-20(4-2)29-15-19(12-26-29)23-22-9-10-24-30(22)16-21(27-23)18-11-25-28(14-18)13-17-7-5-6-8-17;1-3-18(4-2)28-14-17(12-26-28)22-21-7-10-24-30(21)15-20(27-22)16-11-25-29(13-16)19-5-8-23-9-6-19;1-3-15(2)26-13-17(11-23-26)21-20-4-7-22-28(20)14-19(25-21)16-10-24-27(12-16)18-5-8-31(29,30)9-6-18;1-14(2)26-12-16(10-23-26)20-19-5-8-22-28(19)13-18(25-20)15-9-24-27(11-15)17-3-6-21-7-4-17/h9-12,14-17,20H,3-8,13H2,1-2H3;7,10-15,18-19,23H,3-6,8-9H2,1-2H3;4,7,10-15,18H,3,5-6,8-9H2,1-2H3;5,8-14,17,21H,3-4,6-7H2,1-2H3/t;;15-;/m..1./s1
InChIKeyUECQCGVJYZSDTC-INFGGBCXSA-N
MW1624.07 g/mol
LogP14.89
Rot. Bonds22

About 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine

4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine (PubChem CID 161066707) has the molecular formula C86H106N30O2S and a molecular weight of 1624.07 g/mol. Its IUPAC name is 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine.

Molecular Properties

Compound Name4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine
PubChem CID161066707
Molecular FormulaC86H106N30O2S
Molecular Weight1624.07 g/mol
Exact Mass1622.88
IUPAC Name4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine
SMILESCC(C)n1cc(-c2nc(-c3cnn(C4CCNCC4)c3)cn3nccc23)cn1.CCC(CC)n1cc(-c2nc(-c3cnn(C4CCNCC4)c3)cn3nccc23)cn1.CCC(CC)n1cc(-c2nc(-c3cnn(CC4CCCC4)c3)cn3nccc23)cn1.CC[C@@H](C)n1cc(-c2nc(-c3cnn(C4CCS(=O)(=O)CC4)c3)cn3nccc23)cn1
InChIInChI=1S/C23H29N7.C22H28N8.C21H25N7O2S.C20H24N8/c1-3-20(4-2)29-15-19(12-26-29)23-22-9-10-24-30(22)16-21(27-23)18-11-25-28(14-18)13-17-7-5-6-8-17;1-3-18(4-2)28-14-17(12-26-28)22-21-7-10-24-30(21)15-20(27-22)16-11-25-29(13-16)19-5-8-23-9-6-19;1-3-15(2)26-13-17(11-23-26)21-20-4-7-22-28(20)14-19(25-21)16-10-24-27(12-16)18-5-8-31(29,30)9-6-18;1-14(2)26-12-16(10-23-26)20-19-5-8-22-28(19)13-18(25-20)15-9-24-27(11-15)17-3-6-21-7-4-17/h9-12,14-17,20H,3-8,13H2,1-2H3;7,10-15,18-19,23H,3-6,8-9H2,1-2H3;4,7,10-15,18H,3,5-6,8-9H2,1-2H3;5,8-14,17,21H,3-4,6-7H2,1-2H3/t;;15-;/m..1./s1
InChIKeyUECQCGVJYZSDTC-INFGGBCXSA-N
XLogP14.89
TPSA321.52 Ų
H-Bond Donors2
H-Bond Acceptors32
Rotatable Bonds22
Heavy Atoms119
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001624.07
LogP ≤ 514.89
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1032

Analyze 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine?
The IUPAC name of 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine (CID 161066707) is 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine.
What is the SMILES notation for 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine?
The canonical SMILES for 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine is CC(C)n1cc(-c2nc(-c3cnn(C4CCNCC4)c3)cn3nccc23)cn1.CCC(CC)n1cc(-c2nc(-c3cnn(C4CCNCC4)c3)cn3nccc23)cn1.CCC(CC)n1cc(-c2nc(-c3cnn(CC4CCCC4)c3)cn3nccc23)cn1.CC[C@@H](C)n1cc(-c2nc(-c3cnn(C4CCS(=O)(=O)CC4)c3)cn3nccc23)cn1.
What is the InChIKey of 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine?
The InChIKey is UECQCGVJYZSDTC-INFGGBCXSA-N. The full InChI is InChI=1S/C23H29N7.C22H28N8.C21H25N7O2S.C20H24N8/c1-3-20(4-2)29-15-19(12-26-29)23-22-9-10-24-30(22)16-21(27-23)18-11-25-28(14-18)13-17-7-5-6-8-17;1-3-18(4-2)28-14-17(12-26-28)22-21-7-10-24-30(21)15-20(27-22)16-11-25-29(13-16)19-5-8-23-9-6-19;1-3-15(2)26-13-17(11-23-26)21-20-4-7-22-28(20)14-19(25-21)16-10-24-27(12-16)18-5-8-31(29,30)9-6-18;1-14(2)26-12-16(10-23-26)20-19-5-8-22-28(19)13-18(25-20)15-9-24-27(11-15)17-3-6-21-7-4-17/h9-12,14-17,20H,3-8,13H2,1-2H3;7,10-15,18-19,23H,3-6,8-9H2,1-2H3;4,7,10-15,18H,3,5-6,8-9H2,1-2H3;5,8-14,17,21H,3-4,6-7H2,1-2H3/t;;15-;/m..1./s1.
What are the key properties of 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine?
4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine has a molecular weight of 1624.07 g/mol, XLogP of 14.89, 22 rotatable bonds, 2 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-[4-[1-[(2R)-butan-2-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrazin-6-yl]pyrazol-1-yl]thiane 1,1-dioxide;6-[1-(cyclopentylmethyl)pyrazol-4-yl]-4-(1-pentan-3-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;4-(1-pentan-3-ylpyrazol-4-yl)-6-(1-piperidin-4-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine;6-(1-piperidin-4-ylpyrazol-4-yl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrazine is sourced from PubChem (CID 161066707), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).